Donahoe PK - Search Results

1

Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.

Beck TN, Korobeynikov VA, Kudinov AE, Georgopoulos R, Solanki NR, Andrews-Hoke M, Kistner TM, Pépin D, Donahoe PK, Nicolas E, Einarson MB, Zhou Y, Boumber Y, Proia DA, Serebriiskii IG, Golemis EA. Beck TN, et al. Among authors: donahoe pk. Cell Rep. 2016 Jul 19;16(3):657-71. doi: 10.1016/j.celrep.2016.06.043. Epub 2016 Jul 7. Cell Rep. 2016. PMID: 27396341 Free PMC article.

2

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK. Wang T, et al. Among authors: donahoe pk. Cell. 1996 Aug 9;86(3):435-44. doi: 10.1016/s0092-8674(00)80116-6. Cell. 1996. PMID: 8756725 Free article.

3

Müllerian inhibiting substance as a model for the transforming growth factor-beta family: development of new treatment strategies.

Shah PC, Simpson BB, Donahoe PK. Shah PC, et al. Among authors: donahoe pk. Semin Pediatr Surg. 1996 Aug;5(3):182-90. Semin Pediatr Surg. 1996. PMID: 8858765 Review.

4

Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.

Teixeira J, Fynn-Thompson E, Payne AH, Donahoe PK. Teixeira J, et al. Among authors: donahoe pk. Endocrinology. 1999 Oct;140(10):4732-8. doi: 10.1210/endo.140.10.7075. Endocrinology. 1999. PMID: 10499532

5

Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway.

Segev DL, Ha TU, Tran TT, Kenneally M, Harkin P, Jung M, MacLaughlin DT, Donahoe PK, Maheswaran S. Segev DL, et al. Among authors: donahoe pk. J Biol Chem. 2000 Sep 15;275(37):28371-9. doi: 10.1074/jbc.M004554200. J Biol Chem. 2000. PMID: 10874041 Free article.

6

Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo.

Segev DL, Hoshiya Y, Stephen AE, Hoshiya M, Tran TT, MacLaughlin DT, Donahoe PK, Maheswaran S. Segev DL, et al. Among authors: donahoe pk. J Biol Chem. 2001 Jul 20;276(29):26799-806. doi: 10.1074/jbc.M103092200. Epub 2001 May 16. J Biol Chem. 2001. PMID: 11356848 Free article.

7

Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.

Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. Clarke TR, et al. Among authors: donahoe pk. Mol Endocrinol. 2001 Jun;15(6):946-59. doi: 10.1210/mend.15.6.0664. Mol Endocrinol. 2001. PMID: 11376113

8

Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.

Teixeira J, Maheswaran S, Donahoe PK. Teixeira J, et al. Among authors: donahoe pk. Endocr Rev. 2001 Oct;22(5):657-74. doi: 10.1210/edrv.22.5.0445. Endocr Rev. 2001. PMID: 11588147 Review.

9

Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.

Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S. Segev DL, et al. Among authors: donahoe pk. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):239-44. doi: 10.1073/pnas.221599298. Epub 2002 Jan 2. Proc Natl Acad Sci U S A. 2002. PMID: 11773638 Free PMC article.

10

Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.

Donahoe PK, Clarke T, Teixeira J, Maheswaran S, MacLaughlin DT. Donahoe PK, et al. Mol Cell Endocrinol. 2003 Dec 15;211(1-2):37-42. doi: 10.1016/j.mce.2003.09.009. Mol Cell Endocrinol. 2003. PMID: 14656474 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters